verily
-
Alphabet’s Verily launches Covid-19 antibody study
Verily, Alphabet’s life sciences arm, is launching a new study to better understand the immune response to Covid-19 and gain more information on the accuracy of tests.
-
Google: COVID-19 triage website is in early stages of development
After declaring a state of emergency on Friday, Trump announced that Google would be building a website that could route users to drive-thru testing sites for COVID-19. Alphabet’s subsidiary, Verily, said the tool was in the early stages of development, and that it planned to roll out testing in the Bay Area.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Mammoth Biosciences raises $45M Series B round for CRISPR diagnostics, therapeutics development
The latest round of funding, led by Chinese investors, brings the total amount of money raised by the company, co-founded by CRISPR pioneer Jennifer Doudna, to more than $70 million.
-
Artificial Intelligence, Health Tech
Alphabet subsidiary partners with Emory Healthcare
The partnership adds to Verily’s growing work in value-based reimbursement.
-
Verily, Color partner on delivering genetic information for Project Baseline participants
Color vice president for research and scientific affairs Alicia Zhou explained that there is an ethical obligation to provide information on actionable genes, but costs and logistics have previously made doing so prohibitive.
-
Devices & Diagnostics, Diagnostics
Verily and iRhythm join forces to detect silent atrial fibrillation
Verily is being paid by iRhythm Technologies to develop a tool by improving existing hardware and software to effectively diagnose patients with asymptomatic atrial fibrillation.
-
FDA is looking for new companies to test out its pre-cert pilot program
The regulator is opening up the program to 510(k) submissions, instead of its initial focus on companies moving through the De Novo regulatory pathway.
-
Hospitals, Pharma, Health Tech
Alphabet’s Verily boosts its Project Baseline with new health system, pharma partners
The company just announced strategic alliances with Novartis, Otsuka, Pfizer and Sanofi to develop new clinical research programs utilizing the Project Baseline platform across therapeutic areas ranging from cardiovascular disease to oncology to mental health.
-
Google and Verily reveal algorithm for diabetic eye disease screening
The organizations have announced that the first real-world clinical use of the algorithm is happening at the Aravind Eye Hospital in Madurai, India.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Startups, Devices & Diagnostics
J&J acquires surgical robot startup Auris Health for $3.4 billion cash
Redwood City, California-based Auris Health may also receive up to $2.35 billion in additional payments dependent on hitting certain predetermined milestones.
-
Verily’s wearable smartwatch EKG feature gets FDA nod
While the Study Watch was designed as investigational tool, it’s likely the company will integrate features developed on the device onto its more consumer-oriented offerings.
-
Influx of data will change how we classify conditions
At the CES Digital Health Summit, Daniel Kraft and leaders from Fitbit Health Solutions, Verily and Akili Interactive explored how far we’ve come and where we’re going when it comes to digital health.
-
Dexcom’s first-gen CGM sensor developed with Verily won’t see light of day, at least in the U.S.
San Diego-based Dexcom said at the annual J.P. Morgan Healthcare Conference in San Francisco that it’s first-gen product co-developed by Alphabet’s Verily may never get launched in the U.S.
-
Alphabet’s life science arm just raised $1 billion
Alphabet CFO Ruth Porat and Silver Lake Managing Director Egon Durban will be nominated to join Verily’s operating board.
-
Walgreens teams up with Alphabet’s Verily to tackle chronic disease
The initial major focus of the partnership will be medication adherence, which costs the U.S. healthcare system nearly $300 billion annually
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
